Condition: Sleep Disturbances in Smith-Magenis Syndrome · Sponsor: Vanda Pharmaceuticals
This database will be used to better understand the sleep problems of people with SMS. This clinical database will be a part of a larger Smith-Magenis Patient Registry used to create an awareness campaign around SMS and the sleep disturbances that are characteristic of the disorder.
This description comes directly from the study's public registry record.
Vanda Pharmaceuticals · 202-734-3400 · clinicaltrials@vandapharma.com
Always discuss trial participation with your own doctor first.
| Vanda Pharmaceuticals | Washington D.C., District of Columbia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03154697